Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.78 USD | +6.25% | +3.84% | -8.13% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.13% | 498M | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.69% | 22.27B | |
-12.64% | 22.22B | |
-5.20% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- URGN Stock
- News UroGen Pharma Ltd.
- Transcript : UroGen Pharma Ltd., Q2 2023 Earnings Call, Aug 10, 2023